Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs compared
Compare all 5 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs side by side, used for conditions such as hiv infections. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 5 drugs
- 1New
apretude
Cabotegravir
- 2New
isentress
Raltegravir Potassium
- 3New
tivicay
Dolutegravir Sodium
- 4New
tivicay pd
Dolutegravir Sodium
- 5New
vocabria
Cabotegravir Sodium
Frequently asked questions
What is the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drug class?
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 5 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor products, each independently rated.
Are all Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs the same?
No. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs treat?
Per NIH RxClass drug-classification data, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor drugs are used for conditions including hiv infections.
Sources: the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.